Patents by Inventor Paul G. Brunetta

Paul G. Brunetta has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR TREATING LUPUS
    Publication number: 20100303810
    Abstract: A method of treating lupus in a subject eligible for treatment is provided involving administering an effective amount of an antibody that binds to a B-cell surface marker to the subject to provide an initial exposure and a subsequent exposure to the antibody within certain dosing regimens and an article of manufacture therefor.
    Type: Application
    Filed: July 23, 2010
    Publication date: December 2, 2010
    Applicant: GENENTECH, INC.
    Inventor: PAUL G. BRUNETTA
  • PREVENTING AUTOIMMUNE DISEASE
    Publication number: 20090311255
    Abstract: The present application describes a method of preventing an autoimmune disease in an asymptomatic human subject at risk for experiencing one or more symptoms of the autoimmune disease, by administering a CD20 antibody to the subject in an amount to prevent the subject from experiencing one or more symptoms of the autoimmune disease.
    Type: Application
    Filed: August 7, 2009
    Publication date: December 17, 2009
    Applicant: Genentech, Inc.
    Inventors: Paul G. Brunetta, Iqbal S. Grewal, Patricia A. Walicke
  • THERAPY OF NON-MALIGNANT DISEASES OR DISORDERS WITH ANTI-ERBB2 ANTIBODIES
    Publication number: 20090148402
    Abstract: The present application describes treatment of non-malignant indications, such as psoriasis, endometriosis, scleroderma, vascular diseases or disorders, respiratory disease, colon polyps or fibroadenoma, with anti-ErbB2 antibodies (e.g. rhuMAb 2C4).
    Type: Application
    Filed: August 18, 2008
    Publication date: June 11, 2009
    Inventors: Paul G. Brunetta, Mark X. Sliwkowski
  • THERAPY OF OCULAR DISORDERS
    Publication number: 20090136492
    Abstract: The present application describes therapy of ocular disorders using antagonists, such as antibodies, that bind to CD20.
    Type: Application
    Filed: October 26, 2007
    Publication date: May 28, 2009
    Applicant: Genentech, Inc.
    Inventor: PAUL G. BRUNETTA
  • Therapy of non-malignant diseases or disorders with anti-ErbB2 antibodies
    Publication number: 20040258685
    Abstract: The present application describes treatment of non-malignant indications, such as psoriasis, endometriosis, scleroderma, vascular diseases or disorders, respiratory disease, colon polyps or fibroadenoma, with anti-ErbB2 antibodies (e.g. rhuMAb 2C4).
    Type: Application
    Filed: November 21, 2003
    Publication date: December 23, 2004
    Applicant: GENENTECH, INC.
    Inventors: Paul G. Brunetta, Mark X. Sliwkowski